Description

SOUVENAID is an innovative oral nutritional supplement developed by Nutricia, a division of Danone. It is classified as a Food for Special Medical Purposes (FSMP) and is specifically formulated for individuals in the early stages of Alzheimer’s disease, including those with mild cognitive impairment (MCI). This supplement is designed to support memory function and enhance the growth of brain connections, known as synapses.

Intended Use

• Target Audience: Individuals with early Alzheimer’s disease and mild cognitive impairment.
• Usage: To be used in conjunction with a normal diet and not as a meal replacement.
• Supervision: Intended for use under medical supervision.

Clinical Evidence

SOUVENAID is backed by over 20 years of research, including extensive international clinical trials involving more than 2,000 participants. It has been clinically proven to support memory function and slow cognitive decline when taken daily for at least six months, with benefits observed for up to three years. It is important to note that it has not shown benefits for moderate to advanced Alzheimer’s disease or other forms of dementia.

Key Features

• Fortasyn® Connect: Contains a proprietary blend of nutrients.
• Forms: Available in ready-to-drink liquid (125ml bottles) and powder (360g tins).
• Flavors: Liquid comes in Vanilla, Strawberry, and Cappuccino; powder in Vanilla & Banana and Lemon & Orange.
• Dietary Information: Gluten-free, low in lactose, and low-GI, making it suitable for people with diabetes (with recommended blood glucose monitoring).
• Allergen Information: Not suitable for individuals with galactosaemia or allergies to milk protein, fish oil, or soy.

Recommended Usage

• Liquid Form: Consume one 125ml bottle daily, best served chilled. Shake well before use.
• Powder Form: Add three scoops to 100ml water, stir, and consume immediately.
• Storage: Store in a cool, dry place. Refrigerate liquid after opening and use within 24 hours. Keep powder tin airtight and use within two weeks.

Nutritional Content

SOUVENAID is rich in essential nutrients, including:

• Omega-3 Fatty Acids: EPA and DHA
• Choline and B Vitamins
• Antioxidants and Minerals

These components are crucial for supporting brain health and cognitive function.

Safety and Tolerability

SOUVENAID is well tolerated, with high compliance reported in clinical studies. Some users may experience mild side effects such as dizziness, diarrhoea, or headache, similar to those in control groups.

Important Considerations

• Not a Cure: Does not cure or halt the progression of Alzheimer’s disease.
• Not for Prevention: Not indicated for prevention or for moderate/advanced stages of Alzheimer’s disease or other dementias.
• Availability: May not be available in all markets.

SOUVENAID represents a significant advancement in the dietary management of early Alzheimer’s disease, offering a well-researched option to support cognitive health under professional guidance.